
BioCipher Labs wins HealthSprint 2026 medtech programme
By Abha Lohia · Editor ·
Bengaluru
- BioCipher Labs is a Bengaluru-based startup that develops AI-powered molecular diagnostics for infectious diseases
- The company won the HealthSprint 2026 programme alongside Prodancy and Mykare.ai, securing an immersive week-long trip to Israel
- The programme focuses on clinical validation and scaling, with winners gaining access to the Israeli healthcare and innovation ecosystem
What happened
- BioCipher Labs was named a winner of the HealthSprint 2026 medtech startup programme.
- The startup shares this recognition with Prodancy and Mykare.ai.
- Winners receive a fully funded week-long immersive programme in Israel.
- The trip allows startups to engage with the local healthcare and innovation ecosystem.
- Participants will explore global market validation and strategies for scaling their businesses.
- The programme received 175 applications in total.
- Organisers shortlisted 15 startups across three categories: Diagnose, Treat, and Manage.
Why it matters
- The programme prioritised clinical validation and the achievement of fundable milestones.
- Mentors and investors from Israel included representatives from Sheba Medical Centre and eHealth Ventures.
- The selection process evaluated the ability of founders to learn from failure and adapt their business models.
The business
- BioCipher Labs operates as an advanced biotechnology and molecular diagnostics laboratory.
- The company focuses primarily on the diagnosis of infectious diseases.
- It utilizes technologies including PCR, RT-PCR, Next-Generation Sequencing, and CRISPR-based diagnostics.
- The firm integrates AI-driven algorithms to perform real-time analysis of molecular biology and genomics data.
- Operations currently span seven states including Karnataka, Maharashtra, and Tamil Nadu.
- Prodancy developed an indigenous surgical helmet for joint replacement surgeries.
- Mykare.ai provides an AI-native patient management platform for smaller hospitals and clinics.
The founders
In numbers
175Applications received · 2026
15Shortlisted startups · 2026
What happens next
- Winners will travel to Israel to explore international market opportunities.
Words to know
- Molecular diagnostics
- A collection of techniques used to analyse biological markers in the genome and proteome.
- CRISPR
- A technology used for editing genes or detecting specific genetic sequences.
- Next-Generation Sequencing
- A high-throughput method used to determine the sequence of DNA or RNA.
- Clinical validation
- The process of proving that a medical test or device is accurate and effective in a real-world setting.
The numbers around it
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Other articles talking about it
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 29 August 2026 →
Is this BioCipher Labs? Get your “Featured on StopDown” badge →